Author

Lusungu Msumba

Observed names: L Msumba, Msumba, Lusungu

Institutions: Institut Pasteur, Université Paris Cité, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Louis

Observed institutions: Institut Pasteur, Université Paris Cité, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Louis

OpenAlex ID: A5072067772

Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study

2021 · Jared M Baeten, Thesla Palanee-Phillips, et al. · The Lancet HIV · 109

Prevention of HIV-1 Infection with Early Antiretroviral Therapy for the HPTN 052 Study Team*

2011 · Myron S. Cohen, Ying Qing Chen, et al. · 86

Feasibility, safety, and impact of the RTS,S/AS01E malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised introduction of the vaccine in Ghana, Kenya, and Malawi

2024 · Kwaku Poku Asante, Don P Mathanga, et al. · The Lancet · 82

Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa: an economic analysis of the AMBITION-cm trial

2022 · David S Lawrence, Charles Muthoga, et al. · The Lancet Global Health · 33

Development and validation of quantitative PCR assays for HIV-associated cryptococcal meningitis in sub-Saharan Africa: a diagnostic accuracy study

2024 · Tshepiso Mbangiwa, Aude Sturny-Leclère, et al. · The Lancet Microbe · 17

Works count: 6

Citation count: 326

H-index: 5

I10-index: 5